Peter Nurnberg

In addition to MMS, Peter serves on the board of directors of Aspire Bakeries, and he previously served on the board of directors Big Ass Fans. Previously, he was an investor at TPG Capital, and he worked as an investment banker at Goldman Sachs.

Peter earned his MBA from the Stanford Graduate School of Business, where he was a Siebel Scholar, an Arjay Miller Scholar, and the recipient of the Robichek finance award, and his B.A. in Economics and Mathematics from Williams College, where he was the valedictorian.

Suggested For You

perspectives

May 6th, 2025

Why Clinical Trial Simulation Is Reshaping Drug Development: A Q&A with Dr. Aiden Flynn

perspectives

April 24th, 2025

How to Derisk Clinical Development with Unified Trial Design and Regulatory Strategy

perspectives

April 8th, 2025

Updated UK Clinical Trial Regulation: The Key Changes and Impact on Development Safety Update Report (DSUR) Requirements